CANY
INSP icon

Caxton Associates (New York)’s Inspire Medical Systems INSP Stock Holding History

Caxton Associates (New York)’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,796
Closed -$908K – 511
2023
Q2 		$908K Buy
+2,796
New +$799K 0.13% 164
2021
Q3 		– Sell
-1,466
Closed -$283K – 516
2021
Q2 		$283K Hold
1,466
– – 0.03% 331
2021
Q1 		$303K Buy
+1,466
New +$312K 0.03% 279
2020
Q4 		– Sell
-2,118
Closed -$273K – 232
2020
Q3 		$273K Buy
+2,118
New +$233K 0.03% 212

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Caxton Associates (New York)'s INSP Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 2,796 shares — an estimated $908K sold.

Caxton Associates (New York) first reported a position in INSP in Q3 2020 and held it in 4 quarters. The position peaked at $908K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,796 Inspire Medical Systems shares in Q3 2023, an estimated $908K.
  • Caxton Associates (New York) first reported a position in Inspire Medical Systems in Q3 2020 and held it in 4 quarters.
  • Caxton Associates (New York)'s Inspire Medical Systems position peaked at $908K in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.